NEI Research News

In a set of 10 papers in Nature, a network of researchers unveiled an atlas cataloging the location and type of every cell in the adult mouse brain.

Wilmer Eye Institute researchers at Johns Hopkins Medicine have found how oxidative stress and the protein HIF-1 contributes to what kind of age-related macular degeneration (AMD) a patient could develop.

Using atomic force microscopy, researchers at Doheny Eye Institute, an affiliate of University of California Los Angeles, discovered retinal capillary stiffening in diabetic mice that is causally linked to the development of retinopathy

David Williams, Donald Miller, and Austin Roorda, received recognition for the development of instruments that use adaptive optics technologies to capture high-resolution images of the retina.

A multidisciplinary team led by researchers at the Schepens Eye Research Institute of Mass Eye and Ear has identified a promising new strategy for glaucoma cell replacement therapy.

The discovery will enable researchers to better understand eye movement disorders that cause significant visual impairment.

NEI-funded investigators at Washington University in St. Louis discovered a potential new treatment approach to diabetic retinopathy, one of the most common causes of vision loss in the U.S.

Ribosomal protein genes that are found at low levels in adult nerve cells may be very important to axon regeneration.

Members of the National Eye Institute's Audacious Goals Initiative (AGI) published an outline of milestones to reach before commencing clinical trials of regenerative therapies for retinal disease.

Using a technique they developed for studying eye fluid, Stanford Medicine researchers and their collaborators have found a way to measure ocular aging, opening avenues for treatment of numerous eye diseases.